You are here
QT Vascular enrols first patients for Chocolate Touch study
CATALIST-LISTED healthcare company QT Vascular has announced that it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic.
In a filing to the Singapore Exchange on
- CALL +65 6388 3838
- EMAIL email@example.com